Patisiran exposure in early pregnancy: a case report.

Loser, Valentin; Baumgartner, Thomas; Legardeur, Hélène; Panchaud, Alice; Théaudin, Marie (2024). Patisiran exposure in early pregnancy: a case report. Therapeutic advances in neurological disorders, 17, p. 17562864241239755. Sage 10.1177/17562864241239755

[img]
Preview
Text
loser-et-al-2024-patisiran-exposure-in-early-pregnancy-a-case-report.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (119kB) | Preview

We describe here the first case of exposure to patisiran treatment, a small interfering RNA molecule, during early pregnancy of a 36-year-old woman with symptomatic hereditary transthyretin-related amyloidosis. There were no major complications during pregnancy and delivery, except for a postpartum hemorrhage due to uterine atony. Vitamin A levels had to be closely monitored during pregnancy, and vitamin A substitution adapted accordingly. There was no sign of minor or major congenital abnormalities of the baby. One month after delivery, the patient showed slight clinical and electrophysiological signs of neuropathy progression due to patisiran treatment withdrawal. Patisiran infusions were resumed 3 months after delivery. Due to the unknown teratogenic potential of patisiran, the risk of neuropathy worsening associated with withholding treatment must of course be weighed against a potential teratogenic risk of treatment during pregnancy. Vitamin A levels need to be closely assessed, and substitution must be adapted accordingly, to avoid embryofetal adverse outcome due to vitamin A deficiency or toxicity.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)

UniBE Contributor:

Panchaud Monnat, Alice Elke Martine

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1756-2856

Publisher:

Sage

Language:

English

Submitter:

Pubmed Import

Date Deposited:

02 Apr 2024 13:55

Last Modified:

03 Apr 2024 10:03

Publisher DOI:

10.1177/17562864241239755

PubMed ID:

38532802

Uncontrolled Keywords:

Patisiran amyloidosis case report hATTR pregnancy siRNA

BORIS DOI:

10.48350/194955

URI:

https://boris.unibe.ch/id/eprint/194955

Actions (login required)

Edit item Edit item
Provide Feedback